Annual EBITDA:
-$342.21M-$101.72M(-42.30%)Summary
- As of today, DYN annual EBITDA is -$342.21 million, with the most recent change of -$101.72 million (-42.30%) on December 31, 2024.
- During the last 3 years, DYN annual EBITDA has fallen by -$193.28 million (-129.77%).
- DYN annual EBITDA is now -7048.80% below its all-time high of -$4.79 million, reached on December 31, 2018.
Performance
DYN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$113.39M+$1.90M(+1.65%)Summary
- As of today, DYN quarterly EBITDA is -$113.39 million, with the most recent change of +$1.90 million (+1.65%) on September 30, 2025.
- Over the past year, DYN quarterly EBITDA has dropped by -$8.13 million (-7.73%).
- DYN quarterly EBITDA is now -3113.15% below its all-time high of -$3.53 million, reached on September 30, 2019.
Performance
DYN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$446.64M-$8.13M(-1.85%)Summary
- As of today, DYN TTM EBITDA is -$446.64 million, with the most recent change of -$8.13 million (-1.85%) on September 30, 2025.
- Over the past year, DYN TTM EBITDA has dropped by -$133.93 million (-42.83%).
- DYN TTM EBITDA is now -12556.30% below its all-time high of -$3.53 million, reached on September 30, 2019.
Performance
DYN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DYN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -42.3% | -7.7% | -42.8% |
| 3Y3 Years | -129.8% | -170.7% | -149.6% |
| 5Y5 Years | -2245.8% | -751.3% | -2295.6% |
DYN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -129.8% | at low | -186.8% | +7.0% | -167.7% | at low |
| 5Y | 5-Year | -2245.8% | at low | -751.3% | +7.0% | -2295.6% | at low |
| All-Time | All-Time | -7048.8% | at low | -3113.2% | +7.0% | >-9999.0% | at low |
DYN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$113.39M(+1.6%) | -$446.64M(-1.9%) |
| Jun 2025 | - | -$115.29M(+5.4%) | -$438.51M(-11.1%) |
| Mar 2025 | - | -$121.87M(-26.8%) | -$394.78M(-15.5%) |
| Dec 2024 | -$342.21M(-42.3%) | -$96.09M(+8.7%) | -$341.68M(-9.3%) |
| Sep 2024 | - | -$105.26M(-47.1%) | -$312.71M(-16.2%) |
| Jun 2024 | - | -$71.56M(-4.1%) | -$269.13M(-2.1%) |
| Mar 2024 | - | -$68.77M(-2.5%) | -$263.63M(-10.0%) |
| Dec 2023 | -$240.49M(-42.1%) | -$67.12M(-8.8%) | -$239.70M(-13.0%) |
| Sep 2023 | - | -$61.68M(+6.6%) | -$212.11M(-10.3%) |
| Jun 2023 | - | -$66.06M(-47.3%) | -$192.31M(-8.4%) |
| Mar 2023 | - | -$44.84M(-13.4%) | -$177.37M(-6.3%) |
| Dec 2022 | -$169.28M | -$39.53M(+5.6%) | -$166.84M(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$41.88M(+18.1%) | -$178.93M(+0.3%) |
| Jun 2022 | - | -$51.11M(-48.9%) | -$179.56M(-13.4%) |
| Mar 2022 | - | -$34.32M(+33.5%) | -$158.37M(-6.3%) |
| Dec 2021 | -$148.94M(-155.3%) | -$51.62M(-21.4%) | -$148.95M(-18.5%) |
| Sep 2021 | - | -$42.51M(-42.0%) | -$125.72M(-30.2%) |
| Jun 2021 | - | -$29.92M(-20.2%) | -$96.53M(-44.9%) |
| Mar 2021 | - | -$24.90M(+12.3%) | -$66.61M(-59.7%) |
| Dec 2020 | -$58.34M(-299.9%) | -$28.38M(-113.1%) | -$41.70M(-123.7%) |
| Sep 2020 | - | -$13.32M(-150.2%) | -$18.64M(-110.6%) |
| Dec 2019 | -$14.59M(-204.7%) | -$5.32M(-50.9%) | -$8.85M(-150.9%) |
| Sep 2019 | - | -$3.53M | -$3.53M |
| Dec 2018 | -$4.79M | - | - |
FAQ
- What is Dyne Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Dyne Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Dyne Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of DYN is -$342.21M
What is the all-time high annual EBITDA for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual EBITDA is -$4.79M
What is Dyne Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, DYN annual EBITDA has changed by -$101.72M (-42.30%)
What is Dyne Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of DYN is -$113.39M
What is the all-time high quarterly EBITDA for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly EBITDA is -$3.53M
What is Dyne Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, DYN quarterly EBITDA has changed by -$8.13M (-7.73%)
What is Dyne Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of DYN is -$446.64M
What is the all-time high TTM EBITDA for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high TTM EBITDA is -$3.53M
What is Dyne Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, DYN TTM EBITDA has changed by -$133.93M (-42.83%)